Eflornithine Cream and Intense Pulsed Light for Hirsutism in Women
Eflornithine Topical
+ Instense pulsed light
Hair Diseases+4
+ Hirsutism
+ Signs and Symptoms
Treatment Study
Summary
Study start date: July 15, 2025
Actual date on which the first participant was enrolled.Hirsutism is a condition where women experience excessive hair growth in areas where men typically grow hair, like the face. This occurs due to higher sensitivity of hair follicles to male hormones or increased levels of these hormones. The study focuses on women with excessive facial hair, aiming to determine if using eflornithine cream together with intense pulsed light (IPL) treatment is more effective than using eflornithine cream alone. Understanding the best treatment combination could lead to improved management of hirsutism, offering women better options for reducing unwanted facial hair. Participants in the study will receive either eflornithine cream with IPL treatment or eflornithine cream alone. The cream is applied to the affected areas, while IPL is a light-based treatment targeting hair follicles. Researchers will compare the results of the two groups to assess which treatment method is more effective in reducing facial hair. This study does not specify potential risks or benefits, but it aims to identify the most efficient treatment strategy for managing excessive hair growth in women.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.122 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 45 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Gender (Female) Age between 18-45 Years Women with hirsutism as mentioned in the operational definition Exclusion Criteria: Pregnant women Women with severe acne Women with immunodeficiency
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
Khyber Teaching Hospital
Peshawar, PakistanKhyber Teachinng Hospital
Peshawar, Pakistan